Table 3.

Number of Adverse Events and Number of Participants Reporting Adverse Events

		Preschool-aged Children				School-aged Children						Adults
Time Point	Number of	Albendazole, 200 mg	Albendazole, 400 mg	Albendazole, 600 mg	Total	Placebo	Albendazole, 200 mg	Albendazole, 400 mg	Albendazole, 600 mg	Albendazole, 800 mg	Total	Placebo	Albendazole, 200 mg	Albendazole, 400 mg	Albendazole, 600 mg	Albendazole, 800 mg	Total
Before treatment	Symptoms	0	0	1	1	1	0	0	1	1	3	6	10	11	5	7	39
	Participants	0	0	1	1	1	0	0	1	1	3	5	8	8	4	5	30
3 hours after treatment	Adverse events	1	0	1	2	2	3	2	1	3	11	2	4	5	4	5	20
	Participants	1	0	1	2	2	3	2	1	3	11	2	4	5	3	4	18
24 hours after treatment	Adverse events	0	0	0	0	0	0	2	1	0	3	1	2	2	5	1	11
	Participants	0	0	0	0	0	0	2	1	0	3	1	2	2	3	1	9